Yale-New Haven Hospital & Smilow Cancer Center

New Haven, Connecticut 06520

2 studies enrolling now · 7 studies all time

What they study most

Acute Lymphoblastic Leukemia, Bipolar Disorder Type I With Mania, CD33 Positive Acute Myelogenous Leukemia, CTCL, Multiple Myeloma, Sickle Cell Disease, Small Renal Mass, Kidney Cancer

Studies at this site

• A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3) — Recruiting now
• A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma — Recruiting now
• A Study of ABT-199 (Venetoclax) for Cutaneous T Cell Lymphoma (CTCL) — Completed
• Active Surveillance of the Small Renal Mass — Completed
• Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease — Stopped early
• Expanded Access /Compassionate Use Protocol For Relapsed Or Refractory CD33 Positive AML Patients In The USA Without Access To Comparable Or Alternative Therapy — NO_LONGER_AVAILABLE
• A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia — Completed